These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 24164826

  • 1. Post-transplant lymphoproliferative disorder: no relationship to recombinant human growth hormone use in Australian and New Zealand pediatric kidney transplant recipients.
    Longmore DK, Conwell LS, Burke JR, McDonald SP, McTaggart SJ.
    Pediatr Transplant; 2013 Dec; 17(8):731-6. PubMed ID: 24164826
    [Abstract] [Full Text] [Related]

  • 2. Post-transplantation lymphoproliferative disorder in pediatric kidney-transplant recipients - a national study.
    Cleper R, Ben Shalom E, Landau D, Weissman I, Krause I, Konen O, Rahamimov R, Mor E, Bar-Nathan N, Frishberg Y, Davidovits M.
    Pediatr Transplant; 2012 Sep; 16(6):619-26. PubMed ID: 22708682
    [Abstract] [Full Text] [Related]

  • 3. Recombinant growth hormone use pretransplant and risk for post-transplant lymphoproliferative disease--a report of the NAPRTCS.
    Dharnidharka VR, Talley LI, Martz KL, Stablein DM, Fine RN.
    Pediatr Transplant; 2008 Sep; 12(6):689-95. PubMed ID: 18179637
    [Abstract] [Full Text] [Related]

  • 4. Post-transplant lymphoproliferative disorder in pediatric heart transplant recipients.
    Manlhiot C, Pollock-Barziv SM, Holmes C, Weitzman S, Allen U, Clarizia NA, Ngan BY, McCrindle BW, Dipchand AI.
    J Heart Lung Transplant; 2010 Jun; 29(6):648-57. PubMed ID: 20304682
    [Abstract] [Full Text] [Related]

  • 5. Case-control study of risk factors for the development of post-transplant lymphoproliferative disease in a pediatric heart transplant cohort.
    Katz BZ, Pahl E, Crawford SE, Kostyk MC, Rodgers S, Seshadri R, Proytcheva M, Pophal S.
    Pediatr Transplant; 2007 Feb; 11(1):58-65. PubMed ID: 17239124
    [Abstract] [Full Text] [Related]

  • 6. Impact of Epstein-Barr virus donor and recipient serostatus on the incidence of post-transplant lymphoproliferative disorder in kidney transplant recipients.
    Sampaio MS, Cho YW, Shah T, Bunnapradist S, Hutchinson IV.
    Nephrol Dial Transplant; 2012 Jul; 27(7):2971-9. PubMed ID: 22273720
    [Abstract] [Full Text] [Related]

  • 7. Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients.
    Schubert S, Abdul-Khaliq H, Lehmkuhl HB, Yegitbasi M, Reinke P, Kebelmann-Betzig C, Hauptmann K, Gross-Wieltsch U, Hetzer R, Berger F.
    Pediatr Transplant; 2009 Feb; 13(1):54-62. PubMed ID: 18518912
    [Abstract] [Full Text] [Related]

  • 8. Risk for post-transplant lymphoproliferative disorder after polyclonal antibody induction in kidney transplantation.
    Dharnidharka VR, Stevens G.
    Pediatr Transplant; 2005 Oct; 9(5):622-6. PubMed ID: 16176420
    [Abstract] [Full Text] [Related]

  • 9. Incidence and predictors of post-transplant lymphoproliferative disease after kidney transplantation during adulthood and childhood: a registry study.
    Francis A, Johnson DW, Teixeira-Pinto A, Craig JC, Wong G.
    Nephrol Dial Transplant; 2018 May 01; 33(5):881-889. PubMed ID: 29342279
    [Abstract] [Full Text] [Related]

  • 10. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.
    Hurwitz M, Desai DM, Cox KL, Berquist WE, Esquivel CO, Millan MT.
    Pediatr Transplant; 2004 Jun 01; 8(3):267-72. PubMed ID: 15176965
    [Abstract] [Full Text] [Related]

  • 11. The impact of recombinant human growth hormone treatment during chronic renal insufficiency on renal transplant recipients.
    Fine RN, Sullivan EK, Kuntze J, Blethen S, Kohaut E.
    J Pediatr; 2000 Mar 01; 136(3):376-82. PubMed ID: 10700696
    [Abstract] [Full Text] [Related]

  • 12. Lymphoproliferative disorders after adult kidney transplant: epidemiology and comparison of registry report with claims-based diagnoses.
    Kasiske BL, Kukla A, Thomas D, Wood Ives J, Snyder JJ, Qiu Y, Peng Y, Dharnidharka VR, Israni AK.
    Am J Kidney Dis; 2011 Dec 01; 58(6):971-80. PubMed ID: 21930332
    [Abstract] [Full Text] [Related]

  • 13. Posttransplant lymphoproliferative disorder in pediatric renal transplantation.
    Srivastava T, Zwick DL, Rothberg PG, Warady BA.
    Pediatr Nephrol; 1999 Nov 01; 13(9):748-54. PubMed ID: 10603113
    [Abstract] [Full Text] [Related]

  • 14. Post-transplantation lymphoproliferative disorder after kidney transplantation: report of a nationwide French registry and the development of a new prognostic score.
    Caillard S, Porcher R, Provot F, Dantal J, Choquet S, Durrbach A, Morelon E, Moal V, Janbon B, Alamartine E, Pouteil Noble C, Morel D, Kamar N, Buchler M, Mamzer MF, Peraldi MN, Hiesse C, Renoult E, Toupance O, Rerolle JP, Delmas S, Lang P, Lebranchu Y, Heng AE, Rebibou JM, Mousson C, Glotz D, Rivalan J, Thierry A, Etienne I, Moal MC, Albano L, Subra JF, Ouali N, Westeel PF, Delahousse M, Genin R, Hurault de Ligny B, Moulin B.
    J Clin Oncol; 2013 Apr 01; 31(10):1302-9. PubMed ID: 23423742
    [Abstract] [Full Text] [Related]

  • 15. [Diffuse lymphoproliferative disease after renal transplantation and its relation with Epstein-Barr virus. Experience at one center].
    Franco A, Jiménez L, Aranda I, Alvarez L, González M, Rocamora N, Olivares J.
    Nefrologia; 2002 Apr 01; 22(5):463-9. PubMed ID: 12497748
    [Abstract] [Full Text] [Related]

  • 16. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
    Schubert S, Renner C, Hammer M, Abdul-Khaliq H, Lehmkuhl HB, Berger F, Hetzer R, Reinke P.
    J Heart Lung Transplant; 2008 Jan 01; 27(1):100-5. PubMed ID: 18187094
    [Abstract] [Full Text] [Related]

  • 17. Risk factors for posttransplant lymphoproliferative disorder in pediatric liver transplant recipients with cytomegalovirus antigenemia.
    Kim JM, Lee SK, Kim SJ, Joh JW, Kwon CH, Choe YH, Shin M, Kim EY, Moon JI, Jung GO, Choi GS.
    Transplant Proc; 2010 Apr 01; 42(3):895-9. PubMed ID: 20430199
    [Abstract] [Full Text] [Related]

  • 18. Risk factors for post-transplant lymphoproliferative disease in patients with cystic fibrosis.
    Saueressig MG, Boussaud V, Amrein C, Guillemain R, Souilamas J, Souilamas R.
    Clin Transplant; 2011 Apr 01; 25(4):E430-6. PubMed ID: 21518001
    [Abstract] [Full Text] [Related]

  • 19. Post-transplant lymphoproliferative disorder following pediatric heart transplantation.
    Mendoza F, Kunitake H, Laks H, Odim J.
    Pediatr Transplant; 2006 Feb 01; 10(1):60-6. PubMed ID: 16499589
    [Abstract] [Full Text] [Related]

  • 20. Growth, chronic kidney disease and pediatric kidney transplantation: is it useful to use recombinant growth hormone in Colombian children with renal transplant?
    Castañeda DA, López LF, Ovalle DF, Buitrago J, Rodríguez D, Lozano E.
    Transplant Proc; 2011 Nov 01; 43(9):3344-9. PubMed ID: 22099793
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.